Project Grant R43EY037613
- This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) aims to develop and validate a novel Adaptive Optics Optical Coherence Tomography (AO-OCT) system tailored for high-resolution, wide-field retinal imaging in small animal models, specifically mice. The $305,000 project, awarded on September 1, 2025, with an expected completion date of August 31, 2026, has two key objectives: Develop and optimize a portable AO-OCT system with enhanced imaging capabilities...
- This Project Grant award from the National Eye Institute's Vision Research program (CFDA 93.867) provides $179,964 to the University of California, Irvine (UCI) to develop innovative biomarkers for optic neuropathies using deep learning-based analysis of optical coherence tomography (OCT) imagery. The project aims to overcome limitations of current OCT-based diagnostics by employing advanced computational techniques like deep learning, neural fields, and geometric modeling to enhance the...
- This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), is providing $306,462 to Ifocus Imaging LLC to develop a software platform called OCT-ART-DR. The platform will automate the diagnosis and staging of diabetic retinopathy using optical coherence tomography angiography (OCTA) imaging and artificial intelligence. The key products to be delivered under this award include: 1) Improved AI-based segmentation of OCTA image...
- The National Eye Institute (NEI) awarded a $421,136 Project Grant to the University of Maryland, College Park under the Vision Research federal grant program (CFDA 93.867) to explore a novel approach for correcting ocular opacities and enabling high-resolution fundus imaging. The 2-year project aims to demonstrate that neural-network based wavefront shaping can optically correct for ocular opacities, which degrade the performance of optical imaging techniques for the posterior segment of the...
- This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $566,288 to Intelon Optics, Inc. to develop a next-generation Brillouin Optical Scanner System (BOSS) with improved speed, accuracy, and sensitivity compared to the current commercial-grade product. The objective is to translate the University of Maryland's Brillouin research technology into a novel BOSS device that can clearly differentiate mild-to-moderate keratoconus and subclinical keratoconus...
- This $332,179 Project Grant awarded by the National Eye Institute (CFDA 93.867 Vision Research) supports the development of nanobarrier contact lenses that can provide sustained delivery of the drug cysteamine to treat the ocular complications of cystinosis. The lenses are designed to replace the current 8-times daily eye drop regimen, improving patient compliance and reducing side effects from the preservatives and acidic pH in the eye drops. The project aims to demonstrate the lenses can...
- This is a Cooperative Agreement award from the National Eye Institute (NEI), part of the U.S. Department of Health and Human Services, under the Vision Research federal grant program (CFDA 93.867). The $791,994 award, which began on September 1, 2025, supports the development of a next-generation ophthalmic microscope with integrated optical coherence tomography (OCT) imaging capabilities. The project aims to overcome limitations of current ophthalmic surgery microscopes by enabling more...
- The National Eye Institute (NEI) awarded a $602,198 Project Grant under its Vision Research program (CFDA 93.867) to the University of Southern California (USC) to develop an "Attentive Knowledge Device for Visual Assistance" - an artificial intelligence (AI)-powered smartphone app and smart eyeglasses system to better assist people with visual impairments. The project aims to leverage machine vision algorithms and AI techniques to proactively integrate real-time visual information...
- This $257,785 Project Grant was awarded on April 1, 2025 by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867). The grant supports the development of a refillable micromachined lens capsule-based drug delivery device for extended intraocular delivery of biologics and immune-modulating peptides to treat non-infectious uveitis. The key products/services to be delivered under this 4-year grant include: Characterizing and controlling the release of the...
- The Project Grant award of $621,250 from the National Eye Institute's Vision Research program (CFDA 93.867) is supporting the development of a gaze-contingent AI-enabled low vision assistive technology (GALVAT) system. The project is being led by The Johns Hopkins University, in collaboration with the Chicago Lighthouse, Applied Universal Dynamics Corp, and the Illinois Institute of Technology. The goal is to reduce information overload for visually impaired users by defining a gaze-contingent...
The Ovitz Corporation was awarded a $306,171 Project Grant from the National Eye Institute's Vision Research program (CFDA 93.867) to develop AI-driven tools for automating the design of higher-order aberration optics in contact lenses. The key objectives are to: 1) Prepare a training dataset from the company's existing 28,000 wavefront images to train machine learning models; 2) Train and validate the ML models to predict lens designs; and 3) Assess the algorithm's ability to determine lens position on the eye without additional fittings, potentially reducing patient visits. This 1-year project aims to reduce lens design time by up to 40 minutes per lens and eliminate at least one patient fitting session, lowering costs and increasing patient volume for this specialty lens treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $306.2k | 8/28/25 |